AU2173597A - Process for the preparation of tenidap - Google Patents

Process for the preparation of tenidap

Info

Publication number
AU2173597A
AU2173597A AU21735/97A AU2173597A AU2173597A AU 2173597 A AU2173597 A AU 2173597A AU 21735/97 A AU21735/97 A AU 21735/97A AU 2173597 A AU2173597 A AU 2173597A AU 2173597 A AU2173597 A AU 2173597A
Authority
AU
Australia
Prior art keywords
tenidap
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21735/97A
Inventor
Gabor Blasko
Endrene Florian
Gyula Lukacs
Tibor Mezei
Marta Porcs-Makkay
Jozsefne Reiter
Gyula Simig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egis Pharmaceuticals PLC
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar, Egis Pharmaceuticals PLC filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of AU2173597A publication Critical patent/AU2173597A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
AU21735/97A 1996-04-03 1997-04-03 Process for the preparation of tenidap Abandoned AU2173597A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU9600855 1996-04-03
HU9600855A HUP9600855A3 (en) 1996-04-03 1996-04-03 Process for producing tenidap
PCT/HU1997/000013 WO1997036895A1 (en) 1996-04-03 1997-04-03 Process for the preparation of tenidap

Publications (1)

Publication Number Publication Date
AU2173597A true AU2173597A (en) 1997-10-22

Family

ID=89993856

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21735/97A Abandoned AU2173597A (en) 1996-04-03 1997-04-03 Process for the preparation of tenidap

Country Status (3)

Country Link
AU (1) AU2173597A (en)
HU (1) HUP9600855A3 (en)
WO (1) WO1997036895A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY145694A (en) 2005-04-11 2012-03-30 Xenon Pharmaceuticals Inc Spiroheterocyclic compounds and their uses as therapeutic agents
MY158766A (en) 2005-04-11 2016-11-15 Xenon Pharmaceuticals Inc Spiro-oxindole compounds and their uses as therapeutic agents
AR056317A1 (en) * 2005-04-20 2007-10-03 Xenon Pharmaceuticals Inc OXINDOL COMPOUNDS AND PHARMACEUTICAL COMPOSITION
WO2008060789A2 (en) 2006-10-12 2008-05-22 Xenon Pharmaceuticals Inc. Use of spiro-oxindole compounds as therapeutic agents
RU2011119626A (en) 2008-10-17 2012-11-27 Ксенон Фармасьютикалз Инк. SPIROOXINDOL COMPOUNDS AND THEIR APPLICATION AS A THERAPEUTIC
US8101647B2 (en) 2008-10-17 2012-01-24 Xenon Pharmaceuticals Inc. Spiro-oxindole compounds and their use as therapeutic agents
AR077252A1 (en) 2009-06-29 2011-08-10 Xenon Pharmaceuticals Inc ESPIROOXINDOL COMPOUND ENANTIOMERS AND THEIR USES AS THERAPEUTIC AGENTS
CN102753556B (en) 2009-10-14 2015-05-13 泽农医药公司 Synthetic methods for spiro-oxindole compounds
MX343215B (en) 2010-02-26 2016-10-27 Xenon Pharmaceuticals Inc Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents.
AR103636A1 (en) 2015-02-05 2017-05-24 Teva Pharmaceuticals Int Gmbh METHODS OF TREATMENT OF POSTERPEPTIC NEURALGY WITH A TOPICAL FORMULATION OF AN ESPIRO-OXINDOL COMPOUND

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3568776D1 (en) * 1984-02-07 1989-04-20 Pfizer 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
GR850669B (en) * 1984-03-19 1985-07-25 Pfizer
US5059693A (en) * 1989-10-06 1991-10-22 Pfizer Inc. Process for making 3-aroyl-2-oxindole-1-carboxamides

Also Published As

Publication number Publication date
HU9600855D0 (en) 1996-05-28
HUP9600855A3 (en) 1998-04-28
HUP9600855A2 (en) 1998-03-30
WO1997036895A1 (en) 1997-10-09

Similar Documents

Publication Publication Date Title
AU5883098A (en) Process for the preparation of an aldehyde
AU4397597A (en) Novel phytase and process for the preparation thereof
EP0699695A3 (en) Process for the preparation of copolyacetals
IL129759A0 (en) Process for the preparation of benzyl-ethers
AU2734895A (en) Process for the preparation of 3-aryluracils
AU1230595A (en) Process for the preparation of polyalkyl-1-oxa- diazaspirodecane compounds
AU5194798A (en) Process for the preparation of radiopharmaceuticals
AU2173597A (en) Process for the preparation of tenidap
GB9509826D0 (en) Process for the preparation of imidazolutidine
AU5486396A (en) Process for the preparation of spiroindolines
AU7096496A (en) Process for the preparation of 4-methylenepiperidines
AU3783097A (en) Process for the preparation of hexanitrohexaazaisowurtzitanes
AU4468997A (en) Process for the preparation of fluoxetine
GR3035436T3 (en) Process for the preparation of 2-H-heptafluoropropane
AU2074997A (en) Process for the preparation of tetraethyl methylenebisphosphonate
AU9198698A (en) Process for the preparation of substituted 5,6-dihydro-2h-pyran-2-ones
AU2488697A (en) Process for the manufacture of acetonylbenzamides
AU5779998A (en) Process for the preparation of cyanoarylmethylamine
AU1207497A (en) Process for the preparation of para-fluorophenol
IL116493A0 (en) Process for the preparation of sameridine
ZA9510894B (en) Process for the preparation of chloromethylpyridines
EP0831156A4 (en) Process for the preparation of 3-alkoxymethylcephems
AU2788297A (en) Process for the preparation of 3-hydroxypyrrolidine
AU5698696A (en) Process for the preparation of substituted 5-hydroxy-oxazoli din-4-one
AU4208397A (en) Process for the preparation of nizatidine